Log In
BCIQ
Print this Print this
 

EndoTAG-1 (SB05)

Also known as: formerly MBT-0206

  Manage Alerts
Collapse Summary General Information
Company Medigene AG
DescriptionIV paclitaxel formulated with EndoTAG tumor endothelial cell targeting technology
Molecular Target Tubulin
Mechanism of ActionMicrotubule stabilization
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

$5.5M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/17/2015

Undisclosed

$5.5M

Undisclosed

07/16/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today